Anti-IL-2 Receptor Antibodies versus Anti-Thymocyte Globulin for Induction Therapy in Kidney Transplantation

被引：7
|
作者：
Mandelbrot, Didier [1 ]
机构：
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA 02215 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2009年 / 20卷 / 06期
关键词：
RABBIT ANTITHYMOCYTE GLOBULIN; RENAL-ALLOGRAFT RECIPIENTS; CONTAINING TRIPLE THERAPY; ACUTE CELLULAR REJECTION; MYCOPHENOLATE-MOFETIL; BASILIXIMAB INDUCTION; MONOCLONAL-ANTIBODY; IMMUNOPROPHYLAXIS; EFFICACY;
D O I：
10.1681/ASN.2009040389
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1170 / 1171
页数：2
相关论文
共 50 条
  • [1] Efficacy of Early Steroid Withdrawal with Anti-Thymocyte Globulin Induction - Optimal Dose of Anti-Thymocyte Globulin in Korean Kidney Transplantation -
    Park, J. B.
    Chng, Y. S.
    Kim, Y. H.
    Song, K. B.
    Jung, J. H.
    Kim, S-C
    Han, D. J.
    TRANSPLANTATION, 2012, 94 (10) : 989 - 989
  • [2] Intraoperative anti-thymocyte globulin-Fresenius bolus induction therapy in kidney transplantation
    Abou-Jaoude, MM
    Ghantous, I
    Najm, R
    Afif, C
    Almawi, WY
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (07) : 2729 - 2730
  • [3] Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation
    Abou-Jaoude, MM
    Ghantous, I
    Almawi, WY
    MOLECULAR IMMUNOLOGY, 2003, 39 (17-18) : 1083 - 1088
  • [4] Induction in the Elderly: A Comparison of Basiliximab versus Rabbit Anti-Thymocyte Globulin After Kidney Transplantation
    Lee, J.
    Liu, E.
    Aull, M.
    Kapur, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 574 - 574
  • [5] Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review
    Ruan, V.
    Czer, L. S. C.
    Awad, M.
    Kittleson, M.
    Patel, J.
    Arabia, F.
    Esmailian, F.
    Ramzy, D.
    Chung, J.
    De Robertis, M.
    Trento, A.
    Kobashigawa, J. A.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (02) : 253 - 259
  • [6] Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation
    Flaman, Flavia
    Zieroth, Shelley
    Rao, Vivek
    Ross, Heather
    Delgado, Diego H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (11): : 1358 - 1362
  • [7] Optimal Anti-Thymocyte Globulin Dose for Induction Immunosuppression in Kidney Transplantation.
    Mitrokhin, A.
    Goldman, J.
    Trivedi, B.
    Vidyasagar, V.
    Vadivel, N.
    Hart, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 676 - 676
  • [8] RABBIT ANTI-THYMOCYTE GLOBULIN (rATG)-BASED IMMUNOSUPPRESSION INDUCTION IN KIDNEY TRANSPLANTATION
    Goggins, William C.
    Qualey, Angie
    Taber, Tim
    Powelson, John
    Chen, Jeanne
    Robertson, Chris
    Mangus, Richard S.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 180 - 180
  • [9] Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation
    Farney, Alan C.
    Singh, Rajinder P.
    Rogers, Jeffrey
    Ashcraft, Elizabeth
    Doares, William
    Hartmann, Erica L.
    Reeves-Daniel, Amber
    Gautreaux, Michael
    Adams, Patricia L.
    Stratta, Robert J.
    XENOTRANSPLANTATION, 2007, 14 (05) : 382 - 382
  • [10] Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation
    Singh, Rajinder P.
    Famey, Alan
    Rogers, Jeffrey
    Ashcraft, Elizabeth
    Doares, William
    Hartmarm, Erica
    Reeves-Daniel, Amber
    Gautreaux, Michael
    Adams, Patricia
    Stratta, Robert
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 556 - 556
12345